APR 6 - 7 2016
Molecular Diagnostics
34 119 27834

The Inaugural Molecular Diagnostics Virtual Conference is now On Demand! This premiere venue is for scientists, technologists, and professionals to discuss and present the newest advances in molecular diagnostics testing. View this online event at no charge, any time.

Check out this video to learn more about this exciting conference!

Molecular diagnostics is growing rapidly as tools to help analyze biological markers become more advanced.  Molecular diagnostic testing is relevant to both identifying markers associated with disease, and clinical applications such as infectious disease detection, oncology, pharmacogenomics, or genetic disease screening. Techniques can be used to diagnose and monitor disease, detect risk, and determine therapies for individual patients. By analyzing markers unique to a patient and their disease, molecular diagnostics looks toward the future of personalized medicine.

Molecular Diagnostics 2016 features informative presentations from keynote speakers and experts including: Dr. William Valenti, Dr. John Longshore, Dr. Alberto Gutierrez, and Dr. Pieter Cullis. Check out the virtual conference to view these and other great speakers at your convenience.

Earn continuing education credits and enjoy the complementary conference from your desk with no need for travel. Explore the virtual exhibit hall to learn about the latest technologies and techniques for your lab.


Watch webcasts with speakers discussing topics such as:

  • Regulations in Molecular Diagnostics Clinical Laboratory Testing
  • Inherited Genetic Disorders and Prenatal Applications in Modern Medicine
  • Next Generation Sequencing (NGS) in the Clinical Laboratory: Reality vs. Opportunity
  • Precision medicine in Oncology
  • Liquid Biospies: Applications in Molecular Diagnostics
  • Infectious Disease Screening, Diagnosis and Monitoring
  • Molecular Diagnostics Applications in Point of Care
  • Genomic Health

Continuing Education
By participating in this virtual event and watching webcast presentations, you can earn Free Continuing Education (CE) and/or Continuing Medical Education (CME) credits. To earn educational credits, you must view an entire presentation. Following the presentation you must click on the educational credit link provided for that particular speaker and follow the required process. Once you have completed the process, you will receive a certificate for the educational credit.

Use #LRmoldx to follow the conversation


Speakers:

Show Resources
Agenda
All times are Pacific Time
  • APR 06, 2016 06:00 AM PDT
    Speaker: David Wong DMD, DMSc
  • APR 06, 2016 07:30 AM PDT
    Speaker: John Longshore, Ph.D., FACMG
  • APR 06, 2016 09:00 AM PDT
    Speaker: Raed Samara, PhD
  • APR 06, 2016 10:30 AM PDT
    Speaker: Rina Wolf, MHA
  • APR 06, 2016 10:30 AM PDT
    Speaker: Todd DeSantis
  • APR 06, 2016 12:00 PM PDT
    Speaker: William VALENTI, M.D.
  • APR 06, 2016 01:30 PM PDT
    Maja Oktay, MD, PhD
    Associate Professor of Pathology, Albert Einstein Colle...
    Sumanta Goswami, PhD
    Associate Professor of Biology, Albert Einstein College...
  • APR 06, 2016 01:30 PM PDT
    Speaker: Hanna Rennert, PhD, F.A.C.M.G
  • APR 07, 2016 06:00 AM PDT
    Speaker: Philip Low, PhD
  • APR 07, 2016 07:30 AM PDT
    Speaker: Alberto Gutierrez, PhD
  • APR 07, 2016 07:30 AM PDT
    Speaker: Heather Wetzel, MS, LCGC
  • APR 07, 2016 09:00 AM PDT
    Speaker: Michael Donovan, MD, PhD
  • APR 07, 2016 10:00 AM PDT
    Speaker: Pieter Cullis, PhD
  • APR 07, 2016 10:30 AM PDT
    Speaker: Ed Baker, PhD
  • APR 07, 2016 12:00 PM PDT
    Speaker: Rodney Arcenas, PhD, D(ABMM)
  • APR 07, 2016 01:30 PM PDT
    Speaker: Rey Magana
  • Liquid Biopsies
  • APR 06, 2016 06:00 AM PDT
    Speaker: David Wong DMD, DMSc
  • APR 06, 2016 01:30 PM PDT
    Maja Oktay, MD, PhD
    Associate Professor of Pathology, Albert Einstein Colle...
    Sumanta Goswami, PhD
    Associate Professor of Biology, Albert Einstein College...
  • Precision medicine in Oncology
  • APR 06, 2016 07:30 AM PDT
    Speaker: John Longshore, Ph.D., FACMG
  • APR 06, 2016 09:00 AM PDT
    Speaker: Raed Samara, PhD
  • APR 06, 2016 10:30 AM PDT
    Speaker: Todd DeSantis
  • APR 06, 2016 12:00 PM PDT
    Speaker: William VALENTI, M.D.
  • APR 07, 2016 06:00 AM PDT
    Speaker: Philip Low, PhD
  • APR 07, 2016 07:30 AM PDT
    Speaker: Heather Wetzel, MS, LCGC
  • APR 07, 2016 10:00 AM PDT
    Speaker: Pieter Cullis, PhD
  • APR 07, 2016 10:30 AM PDT
    Speaker: Ed Baker, PhD
  • APR 07, 2016 12:00 PM PDT
    Speaker: Rodney Arcenas, PhD, D(ABMM)
  • APR 07, 2016 01:30 PM PDT
    Speaker: Rey Magana
  • Regulations in Molecular Diagnostics Clinical Laboratory Testing
  • APR 06, 2016 10:30 AM PDT
    Speaker: Rina Wolf, MHA
  • Inherited Genetic Disorders and Prenatal Applications in Modern Medicine
  • APR 06, 2016 01:30 PM PDT
    Speaker: Hanna Rennert, PhD, F.A.C.M.G
  • Personlized Medicine
  • APR 07, 2016 07:30 AM PDT
    Speaker: Alberto Gutierrez, PhD
  • New Approaches to Genomic Health: NGS, Exosomes, and Molecular Microbiome Patterns
  • APR 07, 2016 09:00 AM PDT
    Speaker: Michael Donovan, MD, PhD
Speakers

  • John Longshore, Ph.D., FACMG
    Director of Molecular Pathology, Carolinas Pathology Group
    Biography
      After completing his undergraduate work in Applied Biology at Georgia Tech, John received his Ph.D. in Medical Genetics from the University of Alabama at Birmingham and his Doctorate in Medical Genetics at the Greenwood Genetic Center. Since 2001 he has worked with the Carolinas Pathology Group as Director of Molecular Pathology for the Carolinas Laboratory Network. His primary responsibility is supervision of the Molecular Pathology Laboratory which provides state of the art molecular testing services for the hospitals and facilities within the Carolinas HealthCare system. Dr Longshore is a diplomate of the American Board of Medical Genetics in Clinical Molecular Genetics and an active member of the American College of Medical Genetics, the American Society of Human Genetics and the Association for Molecular Pathology. Away from his professional life, John enjoys fly fishing, swimming, travel and spending time with his wife and children.
    • William VALENTI, M.D.
      Senior Vice President for Organizational Advancement, Co-Founder, and Staff Physician, Trillium Health
      Biography
        Dr. Valenti is Senior Vice-president of Strategic Advancement, Staff Physician, and Chief of Innovation at Trillium Health, Rochester, NY. He oversees Trillium Health's research programs, and new program/ service development and implementation. He is the co-founder of Community Health Network (1989), a Trillium Health legacy organization, and has been doing HIV Medicine and primary care since the early 1980s. His clinical interest focuses on streamlining systems of care to ensure accessible and affordable health care for all patients. Dr. Valenti believes that our understanding of population health should translate to the care of individual patients. His mantra is that "You need to practice in the setting that you supervise." He did his post-graduate training in internal medicine/primary care and infectious diseases at the University of Rochester Medical Center/ Strong Memorial Hospital. He is Clinical Associate Professor of Medicine at the University of Rochester School of Medicine and Dentistry. He is chair of the Infectious Diseases Committee of the Medical Society of the State of NY, and, most recently, served on the New York State Health Department's Task Force to End the HIV Epidemic by 2020 (EtE 2020) as co-chair of the Medical Care Committee. As senior vice president for organizational advancement, Dr. Valenti is responsible for aligning the organization's strategic vision with philanthropic resources. In addition to his longtime role as a staff physician and clinical researcher,he will drive progress toward strategic goals and new clinical initiatives through the development of relationships with organizations engaged in the region's healthcare delivery, health policy and system reform.
      • Ed Baker, PhD
        Senior Director, Scientific Affairs at Roche Molecular Diagnostics
        Biography
          Dr. Ed Baker trained received his medical training in the Loma Linda University system. After completing his specialty training in Obstetrics and Gynecology, he practiced in the San Francisco bay area as a community physician for nearly 10 years. In 2002 he became interested in drug development and took a position with Organon Pharmaceuticals which was one of the most active companies focused on Women's health and eventually became the head of the women's health franchise Medical Affairs team. Dr. Baker has been involved in the development and registration of dozens of products for women's health and often lectures and writes on a variety of topics related to women's health. He has taken leadership positions for companies focused on areas outside of women's health. Prior to his current position he was head of Medical Affairs at Actelion Pharmaceuticals, a company that focused its efforts on rare diseases. He was attracted to his current position at Roche Molecular diagnostics because it presents a great opportunity to help shift a longstanding paradigm in cervical cancer screening. Dr. Baker remains a board certified OB/GYN and holds an appointment as Associate Professor of Medicine in the OB/GYN department at UC Davis.
        • Rodney Arcenas, PhD, D(ABMM)
          Clinical Scientist in Microbiology, Immunology, and Molecular, Pathology Consultants of South Broward, LLP, Memorial Healthcare System
          Biography
            Rodney Arcenas earned a B.S. with Honors in Microbiology from the University of Florida in the spring of 1997. He continued his Microbiology training at the University Of South Florida College Of Medicine graduating in 2002 with a M.S. and Ph.D. in Medical Microbiology and Immunology. Dr. Arcenas was then accepted into the Clinical Microbiology Fellowship program at the Mayo Clinic in Rochester, MN. After completing his fellowship, he was hired in 2004 at LabOne, Inc. in Lenexa, Kansas to be their Scientific Director of Microbiology and Immunology. He left LabOne, Inc. in 2006 to join the Pathology Consultants of South Broward (PCSB) as their Clinical Scientist for Microbiology/Molecular Testing and has been there since. In his time with PCSB, Dr. Arcenas has helped to start the Molecular Infectious Disease testing service that has grown from a day-shift (8-hr, Mon - Fri) operation with 2 Medical Technologists to having 5 full time and 3 part time Medical Technologists with 24-hr shifts (Mon - Fri) and an abbreviated 1.5 shifts on the weekends. He also has helped spearhead the implementation of a successful MRSA active surveillance program that started in 2008. Dr. Arcenas is board certified as a Diplomate of the American Board of Medical Microbiology.
          • Philip Low, PhD
            Director of the Purdue Center for Drug Discovery Ralph C. Corley Distinguished Professor Department of Chemistry, Purdue University
            Biography
              Dr. Philip S. Low is the Director of the Purdue University Center for Drug Discovery and the Ralph C. Corley Distinguished Professor of Chemistry. Dr. Low has spent over 39 years exploring novel methods for drug targeting, and characterizing the structure, function, and pathologies of the erythrocyte membrane. He has published >350 scientific articles and has >50 US patents/patents pending. Eight drugs stemming from his research are undergoing human clinical trials and three companies (Endocyte Inc., OnTarget Laboratories Inc., and HuLow LLC) have been founded to commercialize his discoveries. Dr. Low has received an NIH MERIT Award, the ACS Award for Cancer Research (Sosnovsky Award), the AACR Award for Outstanding Chemistry in Cancer Research, both of Purdue's awards for outstanding research (McCoy and Sigma Xi Awards), the University's highest career achievement award (Morrill Award), and numerous other National and International awards. Dr. Low received his B.S. in Chemistry from Brigham Young University (1971) and his Ph.D. in Biochemistry from UCSD (1975).
            • Raed Samara, PhD
              Global Product Manager, NGS, QIAGEN
              Biography
                Raed Samara, PhD is a Global Product Manager for NGS technologies at QIAGEN, with a focus on pre-analytics and targeted enrichment. Prior to joining QIAGEN, he was a postdoctoral fellow at the National Cancer Institute conducting research in the field of cancer immunology with emphasis on identifying strategies to boost the efficacy of cancer vaccines. He received his Ph.D. degree from Georgetown University in tumor biology.
              • Heather Wetzel, MS, LCGC
                Field Applications Scientist, Personalis
                Biography
                  Heather Wetzel is a Field Applications Scientist and Genetic Counselor at Personalis, Inc. She received her Masters in Genetic Counseling from Northwestern University in 2006 and board certification in genetic counseling in 2007. Prior to working at Personalis, Heather worked for 8 years as a clinical Genetic Counselor in specialties including pediatrics, cancer, and prenatal at the University of Illinois, Northwestern, Stanford, and the University of California - San Francisco. Heather currently supports the clinical products at Personalis including the ACE Clinical Exome for Mendelian Diagnostics and the newly launched ACE CancerPlus Test for tumor profiling.
                • Pieter Cullis, PhD
                  Chair, Personalized Medicine Initiative, Director, Life Sciences Institute, University of British Columbia
                  Biography
                    Dr. Pieter Cullis completed his PhD in Physics at the University of British Columbia (UBC) in 1972 and then pursued postdoctoral training in biochemistry at the University of Oxford as an MRC postdoctoral fellow and at the University of Utrecht as a fellow of the European Molecular Biology Organization. He joined the Department of Biochemistry and Molecular Biology at UBC in 1978 and was appointed professor in 1985. Dr. Cullis is an internationally recognized pioneer and leader in the field of lipids, biological membranes and liposomal drug delivery systems. His drug delivery systems have produced improved formulations of several cancer therapies as well as other drug agents. His lipid nanoparticles delivery system is a leading technology worldwide, enabling the therapeutic potential of siRNA. He has published over 300 scientific articles. He has been very active in the development of several biotechnology companies and is recognized as a remarkable researcher and innovator. His work has led to three drugs that have been approved by regulatory agencies in the U.S. and Europe for the treatment of cancer and its complications and five more that have finished Phase I clinical studies. He has trained many graduate students and postdoctoral fellows, several of whom have gone on to distinguished careers in their own right. Dr. Cullis co-founded The Canadian Liposome Company, Inex Pharmaceuticals (now Tekmira Pharmaceuticals), Northern Lipids Inc., Lipex Biomembranes Inc., and, most recently, Acuitas Pharmaceuticals, Precision NanoSystems and Mesentech Inc. In addition, he co-founded and was Scientific Director of the Centre for Drug Research and Development (CDRD) 2004-2010. He has been part of management teams that have raised over $200M in the biotechnology sector in BC. He is an inventor on over 40 patents.
                  • Todd DeSantis
                    Director of Bioinformatics, Second Genome, Inc.
                    Biography
                      Todd DeSantis is Second Genome Co-founder and Senior Director of Bioinformatics. Todd has 17 years of experience designing and implementing bioinformatics solutions for analyzing microbial community dynamics. At Lawrence Berkeley National Laboratory he led the development of novel microbiome assays and analysis pipelines as a Molecular Microbial Ecology Software Developer. He is the chief architect of Greengenes™, an international effort to catalog global microbial diversity that provides microbial ecologists with reference databases for DNA quality assessment, alignment and classification. Todd also served as an analyst for the NIH Human Microbiome Project and has published over 60 scientific papers. At Second Genome, he manages all informatics work including identifying and recruiting microbiome scientist leaders, integration of multi-omics pipelines, cloud deployment for big-data analytics, and therapeutic pathway discovery. At Lawrence Berkeley National Laboratory he architected novel microbiome assays and analysis pipelines as a Molecular Microbial Ecology Software Developer. He also designed and manages Greengenes, an international effort to catalog global microbial diversity that provides microbial ecologists with resources and online tools for DNA quality assessment, alignment and classification. Todd also served as an analyst for the NIH Human Microbiome Project and has authored over 50 manuscripts. At Second Genome, he manages all bioinformatics work and oversees the planning, performance and interpretation of projects and the production of data reports.
                    • Michael Donovan, MD, PhD
                      Board certified anatomic and clinical pathologist, Icahn School of Medicine at Mount Sinai
                      Biography
                        Dr. Michael J. Donovan, PhD, MD is a board certified anatomic and clinical pathologist with subspecialty boards in pediatric pathology. In addition to an academic career at Harvard Medical School and Boston Childrens Hospital, Dr. Donovan was in the biotechnology space for over 15 years and has worked with a variety of companies including Millennium Pharmaceuticals, Genentech, Incyte and most recently served as the Chief Scientific Officer for Aureon Biosciences and the Chief Medical Officer of Exosome Dx. He has spear-headed the utilization of multiplex tissue and fluid-based assays and coupled mathematic applications to produce clinically relevant diagnostic/predictive/prognostic outcome models for a variety of tumor types and disease states. Dr. Donovan is currently the Director of the Biorepository at Sinai and is the Director of the Experimental Pathology program across Mt. Sinai.
                      • Alberto Gutierrez, PhD
                        Director, Office of In Vitro Diagnostics, CDRH
                        Biography
                          Alberto Gutierrez is the director of the Office of In Vitro Diagnostic Device Evaluation and Safety at the Food and Drug Administration. Gutierrez has had a longstanding career with the FDA, joining in 1992 as a reviewer in the FDA's Center for Biologics Evaluation and Research working on vaccine adjuvants and method development for determination of the purity and structure of vaccine components. In 2000, he joined the FDA Center for Devices and Radiological Health as a scientific reviewer, becoming a team leader for Toxicology in 2003, director of the Division of Chemistry and Toxicology Devices in 2005, deputy director of the Office of In Vitro Diagnostic Device Evaluation and Safety in 2007, and office director in 2009. He holds a bachelor's degree from Haverford College and master and doctorate degrees in chemistry from Princeton University.
                        • Sumanta Goswami, PhD
                          Associate Professor of Biology, Albert Einstein College of Medicine
                          Biography
                            Professor Sumanta Goswami received his PhD in biochemistry at the All India Institute of Medical Sciences. After conducting postdoctoral research at the Albert Einstein College of Medicine, he became an assistant professor in the biology department of Yeshiva College in 2006. He also has a secondary appointment in the department of anatomy and structural biology at the Albert Einstein College of Medicine.
                          • Rey Magana
                            Cofounder of the EXO Incubator, Pioneer in exosome nucleic acid technologies
                            Biography
                              Rey Magaña, is a serial entrepreneur with over 25 years experience in life sciences. Mr. Magana is currently cofounder of the EXO Incubator, a Life Sciences technology incubator and accelerator. EXO Incubator's mandate is to exploit the power of its Exosome and Extracellular Vesicles platform technology to potentiate precision medicine and address critical areas of unmet medical need. Among the disease areas of interest are oncology, metabolic disease, genetics, immunology and infectious disease. EXOi is launching and commercializing technologies, product and companies via portfolio programs spanning applications in molecular diagnostics, drug delivery and therapeutics. Previously, he was part of the team that that pioneered extracellular vesicle and exosome nucleic acid technologies for applications in molecular diagnostics, drug delivery and therapeutic. He cofounded Proxy Life Science Holdings a biotechnology company organized to develop those technologies. He also cofounded Perry Scientific a contract research organization specializing in pre-clinical research services supporting early stage pharmaceutical, biopharmaceutical and medical device companies. The company catered to both emerging and established blue chip companies. Rey was responsible for strategy, business development and operations. His key duty was for the development and delivery of custom research services including efficacy, pharmacokinetics and safety studies in areas as diverse as oncology, metabolic diseases, cardiology, dermatology, immunology, drug delivery, cosmetics, nutraceuticals and medical devices.
                            • Maja Oktay, MD, PhD
                              Associate Professor of Pathology, Albert Einstein College of Medicine
                              Biography
                                Dr. Maja Oktay, MD is a pathologist in Bronx, New York. She is currently licensed to practice medicine in New York. She is an Assistant Professor at Albert Einstein College of Medicine.
                              • Hanna Rennert, PhD, F.A.C.M.G
                                Assistant Professor of Pathology and Laboratory Medicine, Weill Medical College of Cornell University
                                Biography
                                  Hanna Rennert, Ph.D., F.A.C.M.G. is Assistant Professor of Pathology and Laboratory Medicine at Weill Medical College of Cornell University, and Director of the Molecular Pathology Laboratory at the New York Presbyterian Hospital – Weill Cornell Medical Center. She received her Ph.D. in Biochemistry from the Technion-Israel Institute of Technology Medical School. Following postdoctoral training at the University of Pennsylvania, Dr. Rennert served in oversight roles within the Molecular Pathology Laboratory in the Department of Pathology and Laboratory Medicine. From 2000 until 2002, she directed a Microarray Research and Development Laboratory at Tel-Aviv Sourasky Medical Center. Dr. Rennert rejoined the University of Pennsylvania School of Medicine in 2002 as a Senior Molecular Genetics Scientist and adjunct faculty in Molecular Pathology. She is certified by the American Board of Medical Genetics in Clinical Molecular Genetics, and is obtaining a certificate in Clinical Epidemiology from the Center for Clinical Epidemiology and Biostatistics at the University of Pennsylvania. Dr. Rennert directed the Molecular Diagnosis and Genotyping Facility within the Pathology Department until July 2005 when she came to Weill Cornell Medical College. Dr. Rennert's primary research interest is the genetic epidemiology of prostate cancer. In collaboration with researchers from Sanjay Gandhi Post Graduate Institute of Medical Sciences in India and the University of Pennsylvania, we established in 2004 a study for examining the role of genetic factors in the disparity in prostate cancer incidence and disease characteristics between high risk (African Americans) and low risk (Asian Indians) populations. Currently, wide-genome scan association studies have identified numerous single nucleotide polymorphisms (SNPs) and susceptibility loci associated with prostate cancer risk, including a region on chromosome 8q which is commonly amplified in prostate cancer. The role of candidate inherited susceptibility gene variations and their association with prostate cancer risk in these two populations are being studied. A second research interest is the development of clinical molecular tests and applications. Her current efforts as the Director of the Molecular Pathology Laboratory at NYPH-WCMC are focused on expanding the Molecular Pathology test menu, particularly in virology, genetics, and oncology. Specific tests under development include quantification assays for the herpes viruses using real-time PCR, pharmacogenetic testing and EGFR/RAS mutation analysis. In addition, in collaboration with clinicians and researchers at the Rogosin Institute, Dr. Rennert's group has developed and implemented a new strategy to screen for mutations in the polycystic kidney disease 1 and 2 genes (PKD1 and PKD2), using a mismatch-specific DNA endonuclease and DHPLC. This work also included the development of an in-silco algorithm for evaluating the pathogenic potential of gene variations of unknown significance (VUS), and she is currently working with her collaborators on automated mutation calling and evaluation of VUS.
                                • Rina Wolf, MHA
                                  VP Commercialization Strategies, Consulting & Industry Affairs, XIFIN, Inc.
                                  Biography
                                    Rina Wolf is a nationally recognized expert in the field of laboratory commercialization and reimbursement, with over 20 years of experience in the diagnostic laboratory industry, specializing in Molecular Diagnostic Laboratories. She lectures extensively on these topics and has consulted for major laboratories and laboratory associations throughout the U.S.. She is a former President and board member of the California Clinical Laboratory Association and is an active participant with the ACLA (American Clinical Laboratory Association) and the Personalized Medicine Coalition. Ms. Wolf also advises and presents to investor audiences, recent speaking engagements include Piper Jaffray, Cowen Group and Bloomberg's G2 Intelligence Lab Investment Forum. Prior to joining XIFIN in 2009, Ms. Wolf held the position of Vice President of Reimbursement and Regulatory Affairs at Axial Biotech, Inc. where she was responsible for creating and implementing their successful reimbursement strategies. Ms. Wolf has also held executive positions in the area of commercialization and reimbursement at RedPath Integrated Pathology, Inc., Genomic Health, Inc., and Esoterix (now LabCorp) and has assisted more than 50 companies. Ms. Wolf has a Bachelor of Arts degree from UCLA and a Masters of HealthCare Administration.
                                  • David Wong DMD, DMSc
                                    Associate Dean of Research and Director of the Oral/Head and Neck Oncology Research Center, UCLA
                                    Biography
                                      David T.W. Wong DMD, DMSc is Felix & Mildred Yip Endowed Professor, Associate Dean of Research and Director of the Oral/Head and Neck Oncology Research Center at UCLA. Dr. Wong is an active scientist in oral cancer and saliva diagnostics research. He has authored over 280 peer reviewed scientific publications. He is a fellow of the American Association for the Advancement of Sciences (AAAS), past member of the ADA Council of Scientific Affairs and the past president of American Association of Dental Research (AADR).
                                    Sponsored By

                                    For information on becoming a sponsor or exhibitor, please click here.


                                    Continuing Education (CME/CE/CEU) Credits

                                    The speakers below have been approved for CME, CE, or CEU credits. To redeem your credits, locate the presentation you watched and click on the CME/CE/CEU buttons for further direction. For more general information regarding continuing education, the processes to receive credits, and the accreditation bodies, Click here


                                    Committee

                                    To download the Program Committee brochure here.


                                    • Bryan Cobb, PhD, FACMG

                                      Dr. Cobb is the acting Director for Clinical Molecular Diagnostics at Roche Diagnostics Corporation where he serves in a scientific advisory role supporting the laboratory scientific community. He obtained his Ph.D. in Medical Genetics at the University of Alabama at Birmingham ...

                                      See more See less
                                    • Shawn Baker, PhD

                                      Dr. Shawn C. Baker is the Chief Science Officer and co-founder of AllSeq. Having received his Ph.D. at the University of California - Davis, he started his career as a Research Scientist at Illumina when it was a 15-person startup. After spending several years at the bench ...

                                      See more See less
                                    • Jason Alter, PhD

                                      Dr. Jason Alter is the Director of Clinical Genomic Affairs for GenomeDx Biosciences. He and his team specialize in the integration of advanced genomic testing with clinical practice. Jason has extensive experience in the field of prostate cancer prognostic assay development and ...

                                      See more See less
                                    • Martin Latterich, PhD

                                      The discovery of proteinaceous disease biomarkers and their clinical validation is critically important for the enablement of molecular diagnostics and ultimately, precision medicine. In spite of the importance of biomarkers, research done in the last two decades has yielded ...

                                      See more See less
                                    • Judd Moul, MD, FACS

                                      Judd W. Moul is James H. Semans, MD Professor of Surgery, Division of Urologic Surgery, and Director of the Duke Prostate Center, Duke Cancer Institute at Duke University Medical Center. Prior to joining Duke, he was Professor of Surgery at the Uniformed Services University of ...

                                      See more See less
                                    • Emily Hollister, PhD

                                      Dr. Hollister is a microbial ecologist and bioinformaticist. She is interested in quantifying and characterizing microbial communities from a wide variety of environments, including the human body. Utilizing high throughput, next-generation DNA and RNA sequence approaches, her ...

                                      See more See less
                                    Help

                                    General LabRoots Questions

                                    For bugs, spam, technical support or questions please call +1-714-463-4673 or email support@labroots.com  
                                    Contact us

                                    Virtual Events and Webinars

                                    Supported Configurations

                                    • Operating System Internet Explorer Firefox Chrome Safari
                                      Vista IE8+ FF10+ Chrome15+
                                      Windows 7 IE8+ FF10+ Chrome15+
                                      Windows 8 IE10 FF10+ Chrome15+
                                      Mac OS X   FF10+ Chrome15+ Safari5.1+
                                    • Cookie settings: session cookies enabled
                                    • Browser configuration must have JavaScript enabled
                                    • Adobe Flash player 10.2 or later

                                    To watch our webinars and virtual events a modern browser such as Chrome, Firefox, Safari, or an updated version of Internet Explorer is required.

                                    Internet Connection

                                    • A minimum of 100Kbps is recommended for audio-only events
                                    • A minimum of 300Kbps is recommended for speaker on-video events

                                    Computer Equipment

                                    • Screen Resolution: Minimum 1024x768
                                    • Video Card: 65,000 colors minimum
                                    • Sound card and speakers (or headphones) for hearing webcast in full format
                                    • Audio Card: 16-bit minimum
                                    • RAM: 512MB of free RAM

                                    Firewall Protocol

                                    • HTTP on port 80 or HTTPS on port 443
                                    • Adobe RTMP on port 1935, 80, or 443 with automatic fall-back to RTMPT (RTMP tunneling) on ports 1935, 80 or 443
                                    • RTMPE (RTMP encrypted) on ports 1935, 80 or 443

                                    Work-At-Home Attendees

                                    • If a corporate VPN is used, confirm that your network traffic is not directed over the company VPN. If it is, please turn off the VPN while attending the virtual event.

                                    For A Seamless Experience

                                    When using a mobile device, FREE Mobile Apps are available:

                                    - For viewing Webinars:

                                    - For viewing Virtual Events

                                    Attendee Guide

                                    • To learn more about how the virtual event works for attendees, download the Attendee Guide (PDF).

                                    Virtual Event and Webinar Support:

                                    Continuing Education (CME/CE) Support

                                    Loading Comments...
                                    Show Resources